We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$510M
AUM Growth
-$913K
Cap. Flow
+$9.23M
Cap. Flow %
1.81%
Top 10 Hldgs %
43.53%
Holding
86
New
2
Increased
32
Reduced
18
Closed
4

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.51M
2
CRM icon
Salesforce
CRM
+$2.16M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$1.84M
4
ABT icon
Abbott
ABT
+$1.18M
5
MSFT icon
Microsoft
MSFT
+$738K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.21M
2
ADBE icon
Adobe
ADBE
+$2.06M
3
BALL icon
Ball Corp
BALL
+$1.53M
4
NVDA icon
NVIDIA
NVDA
+$1.14M
5
MRNA icon
Moderna
MRNA
+$1M

Sector Composition

Rank Sector Weight
1 Technology 32.6%
2 Healthcare 16.34%
3 Industrials 11.65%
4 Consumer Discretionary 9.44%
5 Communication Services 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
26
ExxonMobil
XOM
$615B
$5.33M 1.05%
49,583
-50
-0.1% -$5.85K
MKC icon
27
McCormick & Company Non-Voting
MKC
$14B
$4.71M 0.92%
61,777
+23,398
+61% +$1.84M
CVX icon
28
Chevron
CVX
$378B
$4.27M 0.84%
29,470
+2,420
+9% +$370K
CRWD icon
29
CrowdStrike
CRWD
$202B
$3.43M 0.67%
40,100
– –
PEP icon
30
PepsiCo
PEP
$185B
$2.93M 0.57%
19,238
-2,940
-13% -$482K
UNP icon
31
Union Pacific
UNP
$176B
$2.57M 0.5%
11,250
-45
-0.4% -$10.7K
BALL icon
32
Ball Corp
BALL
$16.6B
$2.5M 0.49%
45,304
-24,915
-35% -$1.53M
ABBV icon
33
AbbVie
ABBV
$448B
$2.33M 0.46%
13,103
– –
CRM icon
34
Salesforce
CRM
$142B
$2.26M 0.44%
+6,764
New +$2.16M
MRK icon
35
Merck
MRK
$307B
$2.2M 0.43%
22,147
– –
HUBS icon
36
HubSpot
HUBS
$11.8B
$2.09M 0.41%
3,000
– –
LLY icon
37
Eli Lilly
LLY
$1.02T
$2.07M 0.41%
2,680
-48
-2% -$39.7K
SPTM icon
38
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.96M 0.38%
27,400
-300
-1% -$21.6K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.29T
$1.91M 0.38%
10,055
– –
ZS icon
40
Zscaler
ZS
$24.2B
$1.8M 0.35%
10,000
+3,500
+54% +$677K
ABNB icon
41
Airbnb
ABNB
$86B
$1.67M 0.33%
12,721
– –
TT icon
42
Trane Technologies
TT
$103B
$1.45M 0.28%
3,915
– –
KO icon
43
Coca-Cola
KO
$353B
$1.35M 0.26%
21,635
– –
NOW icon
44
ServiceNow
NOW
$108B
$1.27M 0.25%
6,000
+3,000
+100% +$608K
PBA icon
45
Pembina Pipeline
PBA
$29.5B
$1.17M 0.23%
31,773
– –
HON icon
46
Honeywell
HON
$71.7B
$1.1M 0.22%
5,151
-181
-3% -$37.7K
IBM icon
47
IBM
IBM
$200B
$1.09M 0.21%
4,939
– –
NSC icon
48
Norfolk Southern
NSC
$75.2B
$880K 0.17%
3,750
– –
PFE icon
49
Pfizer
PFE
$141B
$828K 0.16%
31,200
– –
NVS icon
50
Novartis
NVS
$285B
$786K 0.15%
8,073
-3,960
-33% -$422K
1
2
3 4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q4 2024 Portfolio in Review

As of Q4 2024, Brian C. Broderick held 86 positions worth $510M, down 0.18% from $511M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Brian C. Broderick's Q4 2024 filing shows 2 new, 32 increased, 18 reduced and 4 closed positions. Its largest new stake was Salesforce: 6,764 shares worth $2.26M. The largest sale was Medtronic, an estimated $2.21M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2024 buy was Salesforce: 6,764 shares worth $2.26M.
  • Brian C. Broderick added most to Vertex Pharmaceuticals in Q4 2024, an estimated $2.51M increase.
  • Brian C. Broderick's biggest Q4 2024 reduction was Medtronic, cutting an estimated $2.21M.
  • Brian C. Broderick fully exited Moderna in Q4 2024, selling an estimated $1M.
  • Brian C. Broderick's ten largest holdings make up 44% of its $510M portfolio in Q4 2024.
  • Brian C. Broderick opened 2 new positions and closed 4 in Q4 2024.
  • Brian C. Broderick's portfolio value fell 0.18% quarter-over-quarter to $510M.

Based on Brian C. Broderick's 13F filing for Q4 2024, filed 13 Feb 2025.